Opportunity Information: Apply for PAR 13 390
Apply for PAR 13 390
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Indo US Collaborative Program on Affordable Medical Devices (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Feb 3, 2014 and posted on Nov 13, 2013.
- Applicants must submit their applications by May 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $75,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Small businesses Private institutions of higher education For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Indo-US Collaborative Program on Affordable Medical Devices (R03) (Funding Opportunity Number PAR-13-390) is a National Institutes of Health (NIH) discretionary grant opportunity designed to stimulate early-stage, jointly conducted research and technology development between scientists and engineers in the United States and India. Its central purpose is to support the creation and advancement of affordable diagnostic and therapeutic medical device technologies that can realistically be used in low-resource settings. The emphasis is not just on technical novelty, but on practicality: projects are expected to reflect real constraints commonly found in underserved environments, such as limited infrastructure, cost sensitivity, supply-chain challenges, and the need for robust, easy-to-use solutions.
A defining feature of this announcement is the requirement for true, coordinated collaboration between U.S. and Indian investigators. The program is structured around peer-reviewed collaborative projects where teams in both countries contribute in a complementary way, building on shared goals and mutual benefit rather than a one-sided subcontracting arrangement. NIH highlights that the partnership should be grounded in trust and a shared commitment to producing diagnostic or therapeutic technologies that improve health outcomes for people living in low-resource settings. In practical terms, this points toward projects that may include joint prototyping, iterative design informed by on-the-ground realities, validation strategies that reflect intended-use environments, and a development pathway that keeps affordability and usability at the center.
The funding mechanism is an NIH R03, which typically supports smaller, tightly scoped projects such as feasibility studies, early proof-of-concept work, pilot testing, or initial technology development steps that can position a device concept for later-stage development or larger funding. The listed award ceiling for this opportunity is $75,000, reinforcing that the program is oriented toward focused, foundational work rather than large-scale clinical trials or major multi-year engineering builds. Cost sharing or matching is not required, which lowers barriers for applicants who may not have access to substantial non-federal support.
The opportunity spans multiple health and research domains, reflected in the CFDA listings tied to NIH research areas. These include technological innovation to improve human health (93.286), multiple cancer-related categories covering cause and prevention, detection and diagnosis, treatment, and control (93.393, 93.394, 93.395, 93.399), as well as allergy and infectious diseases, microbiology and infectious diseases, and child health and human development (93.855, 93.856, 93.865). This range signals that NIH was open to a broad set of clinical targets, provided the core requirement is met: the project should advance an affordable diagnostic or therapeutic device relevant to low-resource settings and be carried out through substantive Indo-U.S. collaboration.
Eligibility is broad across U.S.-based organization types and includes many common applicant categories: public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3)), small businesses, for-profit organizations other than small businesses, and various levels of government (state, county, city/township), as well as independent school districts and public housing authorities/Indian housing authorities. The announcement also explicitly includes a set of additional eligible entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and certain tribal governments (including federally recognized tribal governments). At the same time, it clearly restricts foreign participation on the applicant side: non-U.S. (foreign) institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. In other words, while the program is explicitly Indo-U.S. in its collaborative intent, the application must be submitted by an eligible U.S. entity under NIH rules, with collaboration structured in a way that remains compliant with NIH restrictions on foreign components.
Key administrative details place the opportunity historically in the 2013-2016 window. The posted date is November 13, 2013, with a creation date of February 3, 2014. The original and current closing date are both listed as May 7, 2016, and the archive date is June 7, 2016, indicating the announcement is no longer active but remains relevant as a record of NIH priorities and program structure for Indo-U.S. medical device collaboration at that time.
For applicants or researchers reviewing the opportunity for context, the full announcement was hosted through the NIH grants guide (linked as http://grants.nih.gov/grants/guide/pa-files/PAR-13-390.html). NIH also provided support contacts through the NIH Office of Extramural Research (OER) webmaster for access or linking issues (FBOWebmaster@OD.NIH.GOV). Overall, the program can be understood as a targeted, small-grant mechanism meant to catalyze binational teams working on real-world, cost-sensitive medical device solutions, with an explicit focus on diagnostics and therapeutics that can succeed outside well-resourced hospital systems.
FAQs: Indo-US Collaborative Program on Affordable Medical Devices (R03) - PAR-13-390
What is the Indo-US Collaborative Program on Affordable Medical Devices (R03) (PAR-13-390)?
It is a National Institutes of Health (NIH) discretionary grant opportunity intended to stimulate early-stage, jointly conducted research and technology development between scientists and engineers in the United States and India, with a focus on affordable diagnostic and therapeutic medical devices for low-resource settings.
What is the main goal of this funding opportunity?
The central goal is to support the creation and advancement of affordable diagnostic and therapeutic medical device technologies that can realistically be used in low-resource environments, where constraints like limited infrastructure, tight budgets, supply-chain challenges, and the need for robust and easy-to-use tools are common.
What kinds of projects does NIH want to support under this program?
The program is aimed at early, practical technology development work such as feasibility studies, early proof-of-concept research, pilot testing, and initial device development steps that could position a concept for later-stage development or larger funding.
Does the program prioritize novelty or real-world practicality?
The emphasis is not only on technical novelty; projects are expected to be grounded in practicality and designed around real constraints found in underserved and low-resource settings, including affordability and usability.
What does "true, coordinated collaboration" between U.S. and Indian investigators mean in this announcement?
It means the project should be structured as a genuine partnership where both the U.S. and Indian teams contribute in a complementary way toward shared goals, rather than being set up as a one-sided subcontracting arrangement.
Are there examples of collaborative activities that fit the program's intent?
Based on the description, activities aligned with the intent include joint prototyping, iterative design informed by on-the-ground realities, validation strategies that reflect intended-use environments, and a development pathway that keeps affordability and usability at the center.
What is the funding mechanism for this opportunity?
The mechanism is an NIH R03, which typically supports smaller, tightly scoped projects such as feasibility and pilot studies or early technology development.
What is the maximum award amount for this opportunity?
The listed award ceiling is $75,000, indicating the program is oriented toward focused, foundational work rather than large-scale clinical trials or major multi-year engineering efforts.
Is cost sharing or matching required?
No. The opportunity states that cost sharing or matching is not required.
What types of medical devices are in scope?
Affordable diagnostic and therapeutic medical device technologies are in scope, as long as they are relevant to low-resource settings and are developed through substantive Indo-U.S. collaboration.
Which research and health domains are represented in the opportunity?
The opportunity spans multiple NIH-related domains reflected in the CFDA listings, including technological innovation to improve human health and several disease-focused categories (including multiple cancer-related areas, allergy and infectious diseases, microbiology and infectious diseases, and child health and human development).
Which CFDA program areas are referenced?
The CFDA listings tied to this opportunity include 93.286, 93.393, 93.394, 93.395, 93.399, 93.855, 93.856, and 93.865.
Who is eligible to apply as a U.S. applicant organization?
Eligibility is broad and includes public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3)), small businesses, for-profit organizations other than small businesses, and government entities (state, county, city/township), as well as independent school districts and public housing authorities/Indian housing authorities.
Are minority-serving institutions and other specific entity types included as eligible applicants?
Yes. The opportunity explicitly includes HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are explicitly included among eligible entities.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among the eligible entities.
Are tribal governments eligible to apply?
Yes. The eligibility list includes certain tribal governments, including federally recognized tribal governments.
Can a non-U.S. (foreign) institution apply directly as the applicant?
No. Non-U.S. (foreign) institutions are not eligible to apply under the rules stated in the announcement.
Are non-U.S. components of U.S. organizations allowed?
No. The announcement states that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed on projects?
No. Foreign components (as defined by the NIH Grants Policy Statement) are not allowed for this opportunity.
If foreign components are not allowed, how can the program still be Indo-U.S. collaborative?
The opportunity is explicitly Indo-U.S. in intent, but it also states that the application must be submitted by an eligible U.S. entity and that the collaboration must be structured to remain compliant with NIH restrictions on foreign components and non-U.S. applicant eligibility.
What is the time period when this opportunity was open?
The administrative details place this opportunity in the 2013-2016 window, with a posted date of November 13, 2013, and closing information that indicates it ended in 2016.
What are the key dates listed for PAR-13-390?
Posted date: November 13, 2013. Creation date: February 3, 2014. Closing date (original and current): May 7, 2016. Archive date: June 7, 2016.
Is this funding opportunity still active?
No. The closing date is listed as May 7, 2016, and the archive date is June 7, 2016, indicating it is no longer active.
Where was the official NIH announcement posted?
The full announcement was hosted through the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PAR-13-390.html.
Who was listed as a support contact for access or linking issues?
NIH provided a contact through the NIH Office of Extramural Research (OER) webmaster: FBOWebmaster@OD.NIH.GOV.
What overall kind of work was this program designed to catalyze?
It was designed to catalyze small, focused, binational teams working on real-world, cost-sensitive diagnostic and therapeutic medical device solutions intended to succeed outside well-resourced hospital systems.
Browse more opportunities from the same category: Education Health
Next opportunity: Cyber enabled Manufacturing Systems for Direct Digital Manufacturing (CeMS DDM)
Previous opportunity: Chesapeake Bay Program Office Fiscal Year 2014 Request for Proposals for Chesapeake Bay Program Web Support
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 390
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 390) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007 Funding Number: PAR 14 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010 Funding Number: PAR 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003 Funding Number: RFA NR 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012 Funding Number: PAR 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 011 Funding Number: PAR 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01) Apply for PA 14 014 Funding Number: PA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) Apply for PA 14 013 Funding Number: PA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Public Health Impact of the Changing Policy/Legal Environment for Marijuana (R01) Apply for PAS 14 020 Funding Number: PAS 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Discovering Novel Targets The Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 14 025 Funding Number: PA 14 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Mechanisms of Brain Development for Substance Use and Dependence (R01) Apply for PA 14 026 Funding Number: PA 14 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 14 031 Funding Number: PAR 14 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R01) Apply for PA 14 029 Funding Number: PA 14 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R21) Apply for PA 14 030 Funding Number: PA 14 030 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R21) Apply for PA 14 034 Funding Number: PA 14 034 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R01) Apply for PA 14 033 Funding Number: PA 14 033 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 14 036 Funding Number: PA 14 036 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 14 037 Funding Number: PA 14 037 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 14 038 Funding Number: PA 14 038 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) Apply for RFA CA 14 003 Funding Number: RFA CA 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Stage Development of Innovative Technologies for Biospecimen Science (R21) Apply for RFA CA 14 005 Funding Number: RFA CA 14 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 390", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.